SCHEMBL2925908

SCHEMBL2925908

CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)C(O)(CCCCCCCCCCCCCCCC)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 1/20 0.53
BLM P54132 1/20 0.53
HSPE1 P61604 1/20 0.53
GPR84 Q9NQS5 7/20 0.48
FFAR1 O14842 2/20 0.48
MEN1 O00255 1/20 0.48
HPGD P15428 1/20 0.48
RECQL P46063 1/20 0.48
KMT2A Q03164 1/20 0.48
HSD17B10 Q99714 1/20 0.48
FFAR4 Q5NUL3 1/20 0.44
ACACB O00763 1/20 0.44
ACACA Q13085 1/20 0.44
MAPT P10636 1/20 0.43
LCK P06239 1/20 0.43
PPARD Q03181 1/20 0.43
ZDHHC20 Q5W0Z9 1/20 0.43
ZDHHC2 Q9UIJ5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5574489 1.00 HSPD1 (0.53) HSPD1BLMHSPE1GPR84FFAR1
SCHEMBL14916641 1.00 HSPD1 (0.53) HSPD1BLMHSPE1GPR84FFAR1
SCHEMBL6508893 1.00 HSPD1 (0.53) HSPD1BLMHSPE1GPR84FFAR1
SCHEMBL28916960 0.88 HSPD1 (0.43) HSPD1BLMHSPE1GPR84FFAR1
SCHEMBL31266575 0.87 HSPD1 (0.46) HSPD1BLMHSPE1GPR84FFAR1
SCHEMBL17239649 0.85 HSPD1 (0.44) HSPD1BLMHSPE1GPR84FFAR1
SCHEMBL29010539 0.84 GPR84 (0.43) HSPD1BLMHSPE1GPR84FFAR1
SCHEMBL1735473 0.84 HSPD1 (0.54) HSPD1BLMHSPE1GPR84FFAR1
SCHEMBL1735471 0.84 HSPD1 (0.54) HSPD1BLMHSPE1GPR84FFAR1
SCHEMBL28984579 0.82 GPR84 (0.40) HSPD1BLMHSPE1GPR84FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4604746-B1 ORAL PRODUCT COMPRISING THEOBROMINE CONTRAF NICOTEX TOBACCO GMBH (DE) 2026-05-13 EP claimed
EP-2863996-B1 LIQUID COSMETIC COMPOSITION COMPRISING AN OIL, HYDROPHOBIC SILICA AEROGEL PARTICLES AND A WAX WITH A MELTING POINT OF GREATER THAN 60°C OREAL (FR) 2021-03-24 EP claimed
EP-1176949-B1 LIPID PARTICLES ON THE BASIS OF MIXTURES OF LIQUID AND SOLID LIPIDS AND METHOD FOR PRODUCING SAME PHARMASOL GMBH (DE) 2014-12-10 EP claimed
EP-1627668-A1 Pickering emulsion having a low viscosity Beiersdorf Aktiengesellschaft (DE) 2006-02-22 EP claimed
EP-1469821-A1 COSMETIC AND DERMATOLOGICAL CARE OILS CONTAINING WAXES Beiersdorf AG (DE) 2004-10-27 EP claimed
WO-2003061616-A1 COSMETIC AND DERMATOLOGICAL CARE OILS CONTAINING WAXES BEIERSDORF AG (DE) 2003-07-31 WO claimed
EP-0580620-B1 STABLE MULTIPLE EMULSIONS BEIERSDORF AG (DE) 2000-10-18 EP claimed
EP-0580620-A1 STABLE MULTIPLE EMULSIONS Beiersdorf Aktiengesellschaft (DE) 1994-02-02 EP claimed
WO-1992018227-A2 STABLE MULTIPLE EMULSIONS BEIERSDORF AG (DE) 1992-10-29 WO claimed
EP-1888491-B1 ISOALKANE MIXTURE, ITS PREPARATION AND USE BASF SE (DE) 2017-03-01 EP disclosed
CN-105431137-A Formulations of SYK inhibitors GILEAD CONNECTICUT INC 2016-03-23 CN disclosed
US-8911546-B2 Cosmetic composition for the creation of a cosmetic coating having a metallic, multicolored iridescent appearance; and artificial fingernail ECKART GMBH (DE) 2014-12-16 US disclosed
EP-1176949-B1 LIPID PARTICLES ON THE BASIS OF MIXTURES OF LIQUID AND SOLID LIPIDS AND METHOD FOR PRODUCING SAME PHARMASOL GMBH (DE) 2014-12-10 EP disclosed
EP-2654665-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) 2013-10-30 EP disclosed
EP-0669323-A1 Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation HAARMANN & REIMER GMBH (DE) 1995-08-30 EP disclosed
WO-1995017882-A1 CORTICOSTEROID-CONTAINING W/O EMULSION LOTION BEIERSDORF AG (DE) 1995-07-06 WO disclosed
EP-0580620-A1 STABLE MULTIPLE EMULSIONS Beiersdorf Aktiengesellschaft (DE) 1994-02-02 EP disclosed
EP-0461497-B1 Use of selective hydrogenated styrol-butadien-copolymers in cosmetic and pharmaceutical compositions BASF AG (DE) 1993-10-20 EP disclosed
WO-1992018227-A2 STABLE MULTIPLE EMULSIONS BEIERSDORF AG (DE) 1992-10-29 WO disclosed
EP-0461497-A1 Use of selective hydrogenated styrol-butadien-copolymers in cosmetic and pharmaceutical compositions BASF Aktiengesellschaft (DE) 1991-12-18 EP disclosed